Drug Discovery Biology

Projects

Projects per year 2002 2013 2015 2017 2018 2019 2020 2021 2022 2023 2030

• 3 Curtailed
• 11 Not started
• 42 Active
• 189 Finished

Projects per year

Search results

• Active

  Efficient and Effective Modelling of Protein Structure with Dynamics

  Webb, G. (Primary Chief Investigator (PCI)), May, L. (Chief Investigator (CI)) & Whisstock, J. (Chief Investigator (CI))

  1/07/25 → 30/06/26

  Project: Research

• Understanding how neural circuit activity is controlled by adenosine

  Imlach, W. (Primary Chief Investigator (PCI)), Christopoulos, A. (Chief Investigator (CI)), De Koninck, Y. (Partner Investigator (PI)) & Spanswick, D. (Partner Investigator (PI))

  ARC - Australian Research Council, Monash University – Internal Department Contribution

  25/03/25 → 24/03/28

  Project: Research

• Development of a P2X1 receptor antagonist for use as a male contraceptive

  Bennetts, F. (Primary Chief Investigator (PCI)), Ventura, S. (Supervisor) & Thal, D. (Supervisor)

  17/03/25 → 17/03/27

  Project: Research

• Are lymphatics a regulator of skeletal muscle growth, metabolism & renewal?

  Trevaskis, N. (Primary Chief Investigator (PCI)) & Turpin-Nolan, S. (Chief Investigator (CI))

  1/02/25 → 31/01/28

  Project: Research

• Development of Allosteric and Bitopic Ligands to Tune Receptor Signalling

  Scammells, P. (Primary Chief Investigator (PCI)) & Christopoulos, A. (Chief Investigator (CI))

  ARC - Australian Research Council

  29/01/25 → 28/01/28

  Project: Research

• Dynamics of calcitonin family receptor activation

  Josephs, T. (Primary Chief Investigator (PCI)) & Sexton, P. (Chief Investigator (CI))

  ARC - Australian Research Council, Monash University – Internal School Contribution

  14/01/25 → 13/01/28

  Project: Research

• Adenosine A1 receptor negative allosteric modulators as novel pharmacological interventions for heart failure.

  TN Nguyen, A. (Primary Chief Investigator (PCI)) & May, L. (Chief Investigator (CI))

  10/01/25 → 31/12/25

  Project: Research

• Impact of biased agonism at the GLP-1R in the treatment of obesity and type 2 diabetes

  Hutchinson, D. (Primary Chief Investigator (PCI)), Cary, B. (Chief Investigator (CI)), Wootten, D. (Associate Investigator (AI)), Kebede, M. (Associate Investigator (AI)) & Sexton, P. (Associate Investigator (AI))

  1/01/25 → 31/12/28

  Project: Research

• Leveraging cryo-EM and protein engineering to elucidate GPCR function

  Cary, B. (Primary Chief Investigator (PCI))

  ARC - Australian Research Council, Monash University – Internal School Contribution

  1/01/25 → 31/12/27

  Project: Research

• Understanding structure, dynamics and function of receptor splice variants

  Piper, S. (Primary Chief Investigator (PCI))

  1/01/25 → 31/12/27

  Project: Research

• Understanding structure, dynamics and function of receptor splice variants

  Piper, S. (Primary Chief Investigator (PCI))

  1/01/25 → 31/12/26

  Project: Research

• G protein-coupled receptor Response Mechanisms to Environmental Pollutants

  TN Nguyen, A. (Primary Chief Investigator (PCI))

  ARC - Australian Research Council, Monash University – Internal School Contribution

  1/01/25 → 31/12/27

  Project: Research

• How lipid binding proteins shape the activity of nuclear hormone receptors

  Halls, M. (Primary Chief Investigator (PCI)) & Scanlon, M. (Chief Investigator (CI))

  ARC - Australian Research Council

  31/12/24 → 30/12/27

  Project: Research

• Automating quantitative analysis of goblet cells and mucus components

  Rowe, M. (Primary Chief Investigator (PCI)) & Poole, D. (Chief Investigator (CI))

  Histochemical Society Inc

  1/10/24 → 30/09/25

  Project: Research

• Molecular insights into the allosteric regulation of opioid receptors

  Batista Gondin, A. (Primary Chief Investigator (PCI))

  ARC - Australian Research Council

  6/07/24 → 4/08/28

  Project: Research

• Mechanistic understanding of biased agonism and dimerisation for co-targeting incretin receptors for metabolic diseases

  Wootten, D. (Primary Chief Investigator (PCI))

  1/01/24 → 31/12/28

  Project: Research

• Structure determination of GPCR heteromers

  Sexton, P. (Primary Chief Investigator (PCI)), Wootten, D. (Chief Investigator (CI)), Belousoff, M. (Chief Investigator (CI)) & Shepard, R. (Chief Investigator (CI))

  27/07/23 → 26/07/27

  Project: Research

• Advancing Preclinical Development of Novel GPCR-targeted Therapeutics for Heart Failure

  Ritchie, R. (Primary Chief Investigator (PCI)), Figtree, G. A. (Chief Investigator (CI)), Qin, C. H. (Chief Investigator (CI)), May, L. (Chief Investigator (CI)), Nicholls, S. (Chief Investigator (CI)), Taylor, A. (Chief Investigator (CI)), Yang, J. Y. H. (Chief Investigator (CI)), Shackleford, D. (Chief Investigator (CI)), Schiattarella, G. (Chief Investigator (CI)), Pinto, A. (Chief Investigator (CI)), Drummond, G. (Chief Investigator (CI)), Horowitz, J. D. (Chief Investigator (CI)), Bubb, K. (Chief Investigator (CI)), Ng, H. H. (Chief Investigator (CI)), Vecchio, L. (Associate Investigator (AI)), Nelson, A. (Associate Investigator (AI)), Kirkpatrick, C. (Associate Investigator (AI)), McDonald, C. (Associate Investigator (AI)), Febbraio, M. (Associate Investigator (AI)), Vinh, A. (Associate Investigator (AI)), Odiba, J. (Associate Investigator (AI)), Brown, H. (Associate Investigator (AI)) & Stupple, P. (Chief Investigator (CI))

  1/02/23 → 31/01/26

  Project: Research

• The physiological importance of GLP-1R and GIPR dimerisation

  Wootten, D. (Primary Chief Investigator (PCI)) & Hutchinson, D. (Chief Investigator (CI))

  ARC - Australian Research Council, Monash University – Internal School Contribution

  2/01/23 → 1/01/26

  Project: Research

• Structure and dynamics of class B1 G protein coupled receptors

  Wootten, D. (Primary Chief Investigator (PCI)), Belousoff, M. (Chief Investigator (CI)) & Josephs, T. (Chief Investigator (CI))

  ARC - Australian Research Council, Monash University – Internal School Contribution

  2/01/23 → 1/01/26

  Project: Research

• Cryo-electron microscopy determination of G protein-coupled receptor states

  Zhang, C. (Primary Chief Investigator (PCI))

  1/01/23 → 29/12/26

  Project: Research

• Modulation of the M4 muscarinic receptor for the treatment of schizophrenia

  Valant, C. (Primary Chief Investigator (PCI)), Capuano, B. (Chief Investigator (CI)), Choy, C. (Chief Investigator (CI)), Thal, D. (Associate Investigator (AI)), Miao, Y. (Associate Investigator (AI)), Christopoulos, A. (Associate Investigator (AI)), Felder, C. (Associate Investigator (AI)) & Pantellis, C. (Associate Investigator (AI))

  1/01/23 → 31/12/26

  Project: Research

• Harnessing Endogenous Opioids to Treat Gut Motility Disorders and Pain

  Poole, D. (Primary Chief Investigator (PCI)), Valant, C. (Chief Investigator (CI)), Carbone, S. (Chief Investigator (CI)), Mobbs, J. (Chief Investigator (CI)), Thal, D. (Associate Investigator (AI)), Scammells, P. (Associate Investigator (AI)), King, S. K. (Associate Investigator (AI)), Imlach, W. (Associate Investigator (AI)), Hamilton, J. A. (Associate Investigator (AI)) & Veldhuis, N. (Associate Investigator (AI))

  1/01/23 → 31/12/26

  Project: Research

• Development of a New Class of Formyl Peptide Receptor 1 (FPR1) Biased Agonists for the Treatment of Myocardial Infarction

  Ritchie, R. (Primary Chief Investigator (PCI)), Stupple, P. (Chief Investigator (CI)), Qin, C. H. (Chief Investigator (CI)), May, L. (Chief Investigator (CI)), Vecchio, L. (Chief Investigator (CI)), Figtree, G. A. (Chief Investigator (CI)), Shackleford, D. (Chief Investigator (CI)), Chong, J. J. H. (Chief Investigator (CI)), Charman, S. (Associate Investigator (AI)) & McDonald, C. (Associate Investigator (AI))

  1/01/23 → 31/12/25

  Project: Research

• Addressing the poor medication adherence in prevention of cardiovascular mortality and morbidity in Australia: development of a clinical decision support tool

  Talic, S. (Primary Chief Investigator (PCI)), Ademi Delaney, Z. (Chief Investigator (CI)), Liew, D. (Chief Investigator (CI)), Bell, S. (Chief Investigator (CI)), Reid, C. (Chief Investigator (CI)), Green, S. (Chief Investigator (CI)), Ilomaki, J. (Chief Investigator (CI)), Zomer, E. (Chief Investigator (CI)), Berkovic, D. (Chief Investigator (CI)), Lybrand , S. (Chief Investigator (CI)) & Stratton, G. (Chief Investigator (CI))

  1/06/22 → 31/05/26

  Project: Research

• Towards new therapeutics for neurofibromatosis-linked cancers and tumour growth

  Ellisdon, A. (Primary Chief Investigator (PCI)) & Halls, M. (Chief Investigator (CI))

  1/06/22 → 1/06/26

  Project: Research

• Novel GPR52 agonists for schizophrenia / Phrenix Therapeutics

  Stewart, G. (Primary Chief Investigator (PCI)), Langmead, C. (Chief Investigator (CI)), Nithianantharajah, J. (Chief Investigator (CI)) & Baell, J. (Chief Investigator (CI))

  1/06/22 → …

  Project: Research

• Pre-clinical evaluation of selective adenosine A1 receptor positive allosteric modulators for the treatment of drug-resistant epilepsy

  Kwan, P. (Primary Chief Investigator (PCI)), May, L. (Chief Investigator (CI)), Rollo, B. (Chief Investigator (CI)), O'Brien, T. (Chief Investigator (CI)), Casillas-Espinosa, P. (Chief Investigator (CI)), Howden, S. (Chief Investigator (CI)), Christopoulos, A. (Chief Investigator (CI)), Gregory, K. (Chief Investigator (CI)), Scammells, P. (Chief Investigator (CI)), Baltos, J.-A. (Chief Investigator (CI)), Elliott, D. (Chief Investigator (CI)), TN Nguyen, A. (Chief Investigator (CI)), Langmead, C. (Chief Investigator (CI)), Antonic-Baker, A. (Chief Investigator (CI)), Sumer, H. (Chief Investigator (CI)), Javaid, S. (Associate Investigator (AI)) & Gu, J. (Chief Investigator (CI))

  1/06/22 → 31/05/27

  Project: Research

• Development of approaches for inactive, antagonist bound GPCR structures determination

  Wootten, D. (Primary Chief Investigator (PCI)), Sexton, P. (Chief Investigator (CI)), Belousoff, M. (Chief Investigator (CI)), Johnson, R. (Chief Investigator (CI)) & Han, S. (Chief Investigator (CI))

  22/02/22 → 21/02/26

  Project: Research

• ASHRA: Australian Stroke and Heart Research Accelerator (ASHRA)

  Nicholls, S. (Primary Chief Investigator (PCI)), Kovacic, J. C. (Chief Investigator (CI)), Zoungas, S. (Chief Investigator (CI)), Neal, B. C. (Chief Investigator (CI)), Chow, C. K. (Chief Investigator (CI)), Figtree, G. A. (Chief Investigator (CI)), Campbell, B. C. V. (Chief Investigator (CI)), Maple-Brown, L. J. (Chief Investigator (CI)), Brown, A. D. H. (Chief Investigator (CI)), Hayward, C. S. (Chief Investigator (CI)), Hill, A. (Chief Investigator (CI)), Hool, L. C. (Chief Investigator (CI)), Currie, P. (Chief Investigator (CI)), Rodgers, A. (Chief Investigator (CI)), Arnott, C. (Chief Investigator (CI)), Wu, J. H. Y. (Chief Investigator (CI)), Kritharides, L. (Chief Investigator (CI)), Ugander, M. (Chief Investigator (CI)), Chiang, J. (Chief Investigator (CI)), Davis, S. M. (Chief Investigator (CI)), Donnan, G. A. (Chief Investigator (CI)), Yan, B. (Chief Investigator (CI)), Barr, E. L. M. (Chief Investigator (CI)), Breen, J. (Chief Investigator (CI)), Barclay, J. (Chief Investigator (CI)), Brown, H. (Chief Investigator (CI)), Correa, M. (Chief Investigator (CI)), Wu, C. (Chief Investigator (CI)), Butters, J. (Chief Investigator (CI)), Glass, P. (Chief Investigator (CI)), Ritchie, R. (Chief Investigator (CI)), Vandenburg, J. (Chief Investigator (CI)), Patel, A. (Chief Investigator (CI)), Semsarian, C. (Chief Investigator (CI)), Martino, M. (Chief Investigator (CI)), Laranjo, L. (Chief Investigator (CI)), Thiagalingam, A. (Chief Investigator (CI)), Sivagangabalan, G. (Chief Investigator (CI)), Fox, K. (Chief Investigator (CI)), Rice, H. (Chief Investigator (CI)), Ali, M. (Chief Investigator (CI)), Francisco, J. (Chief Investigator (CI)), Dawidowska, I. (Chief Investigator (CI)), Greenway, A. (Chief Investigator (CI)), Prowse, A. B. J. (Chief Investigator (CI)), Delbaere, K. (Chief Investigator (CI)), Gray, P. (Chief Investigator (CI)) & Hennock, J. (Chief Investigator (CI))

  10/01/22 → 15/02/26

  Project: Research

• alpha1-adrenoceptor protein structures and selective tools: towards novel treatments for heart failure and Alzheimer’s disease

  Scott, D. J. (Primary Chief Investigator (PCI)), Abdul Ridha, A. (Chief Investigator (CI)), Chalmers, D. (Chief Investigator (CI)), Draper-Joyce, C. (Associate Investigator (AI)), Gooley, P. R. (Associate Investigator (AI)), Adlard, P. A. (Associate Investigator (AI)), Lankadeva, Y. R. (Associate Investigator (AI)), Betrie, A. H. (Associate Investigator (AI)), Graham, B. (Associate Investigator (AI)) & Thal, D. (Associate Investigator (AI))

  NHMRC - National Health and Medical Research Council (Australia)

  1/01/22 → 31/12/25

  Project: Research

• A personalised pharmacogenomic approach to inform autosomal dominant hypocalcaemia treatment

  Josephs, T. (Primary Chief Investigator (PCI))

  1/01/22 → 31/12/26

  Project: Research

• Targeting the brain and sympathetic nervous system to improve outcomes in cancer cachexia

  Lockie, S. (Primary Chief Investigator (PCI)), Walton, K. (Associate Investigator (AI)), Andrews, Z. (Associate Investigator (AI)), Stark, R. (Associate Investigator (AI)), Oldfield, B. (Associate Investigator (AI)), Sloan, E. (Associate Investigator (AI)) & Gregorevic, P. (Associate Investigator (AI))

  1/01/22 → 31/12/25

  Project: Research

• Impact of membrane composition on cholecystokinin receptor structure and function

  Miller, L. J. (Primary Chief Investigator (PCI)) & Sexton, P. (Chief Investigator (CI))

  1/01/22 → 30/11/25

  Project: Research

• Positive allosteric modulation of anti-convulsant G protein-coupled receptor signalling to treat drug-resistant epilepsy

  May, L. (Primary Chief Investigator (PCI)), Webb, G. (Chief Investigator (CI)), Carlsson, J. (Chief Investigator (CI)), Baltos, J.-A. (Chief Investigator (CI)), TN Nguyen, A. (Chief Investigator (CI)), Christopoulos, A. (Associate Investigator (AI)), Miao, Y. (Associate Investigator (AI)), O'Brien, T. (Associate Investigator (AI)), Rollo, B. (Associate Investigator (AI)), Casillas-Espinosa, P. (Associate Investigator (AI)), Gregory, K. (Associate Investigator (AI)), Scammells, P. (Associate Investigator (AI)) & Nguyen, T. (Associate Investigator (AI))

  1/01/22 → 31/12/25

  Project: Research

• Cryo‐EM structure determination of G protein‐coupled receptors

  Sexton, P. (Primary Chief Investigator (PCI)), Wootten, D. (Chief Investigator (CI)), Belousoff, M. (Chief Investigator (CI)), Nar, H. (Partner Investigator (PI)), Weichert, D. (Supervisor), Ebenhoch, R. (Supervisor), Ou, Q. (Chief Investigator (CI)) & Lee, D. (Chief Investigator (CI))

  21/09/21 → 21/09/25

  Project: Research

• ARC Industrial Transformation Training Centre for Cryo-Electron Microscopy of Membrane Proteins for Drug Discovery

  Sexton, P. (Primary Chief Investigator (PCI)), Rouiller, I. (Chief Investigator (CI)), Wootten, D. (Chief Investigator (CI)), van Oijen, A. (Chief Investigator (CI)), Parker, M. W. (Chief Investigator (CI)), Lucet, I. (Partner Investigator (PI)), Griffin, M. D. W. (Chief Investigator (CI)), Adams, D. J. (Chief Investigator (CI)), Czabotar, P. E. (Partner Investigator (PI)), Flocco, M. (Partner Investigator (PI)), Han, S. (Partner Investigator (PI)), Shepherd, R. (Partner Investigator (PI)), Ciferri, C. (Partner Investigator (PI)), Williams, P. A. (Partner Investigator (PI)), Brown, D. (Partner Investigator (PI)), Schreuder, H. (Partner Investigator (PI)), Reedtz-Runge, S. (Partner Investigator (PI)), Drinkwater, C. (Partner Investigator (PI)), Howard, B. L. (Partner Investigator (PI)), Betigeri, G. (Partner Investigator (PI)), Pryor, E. (Partner Investigator (PI)), How, J. (Project Manager) & Christopoulos, T. (Chief Investigator (CI))

  Boehringer Ingelheim (Germany), AstraZeneca (United Kingdom)

  23/03/21 → 23/03/27

  Project: Research

• Development of novel therapies to treat obesity related metabolic diseases

  Febbraio, M. (Primary Chief Investigator (PCI))

  1/01/21 → 31/12/25

  Project: Research

• Using protein structure and dynamics to facilitate drug discovery

  Thal, D. (Primary Chief Investigator (PCI))

  1/01/21 → 31/12/25

  Project: Research

• Understanding GPCR signalling networks

  Halls, M. (Primary Chief Investigator (PCI))

  Equity Trustees Limited

  30/11/20 → 30/11/25

  Project: Research

• Formyl peptide receptor biased agonists as novel cardioprotective agents against myocardial infarction.

  Vecchio, L. (Primary Chief Investigator (PCI))

  25/08/20 → 31/12/28

  Project: Research

• Understanding the impact of anaesthetic technique and neural-inflammatory signalling on cancer recurrence and metastasis.

  Dubowitz, J. A. (Chief Investigator (CI)) & Sloan, E. (Chief Investigator (CI))

  1/01/17 → …

  Project: Other

• Not started

  Allosteric modulation of muscarinic receptors for the treatment of neurocognitive deficits

  Christopoulos, A. (Primary Chief Investigator (PCI))

  1/01/26 → 31/12/30

  Project: Research

• Harnessing protein allostery to accelerate drug discovery

  Thal, D. (Primary Chief Investigator (PCI))

  1/01/26 → 31/12/30

  Project: Research

• Developing safer therapeutic approaches for the treatment of pain via allosteric regulation of opioid receptors

  Batista Gondin, A. (Primary Chief Investigator (PCI))

  1/09/25 → 31/08/30

  Project: Research

• Novel Chemical Tools to Study Cathepsin X Activation

  Edgington-Mitchell, L. (Primary Chief Investigator (PCI))

  Project: Research

• Nano-Bioscience Imaging Facility

  Caruso, F. (Primary Chief Investigator (PCI)), Davis, T. (Chief Investigator (CI)), Kent, S. (Chief Investigator (CI)), Porter, C. (Chief Investigator (CI)), Johnston, A. (Chief Investigator (CI)), Qiao, G. (Chief Investigator (CI)), Sexton, P. (Chief Investigator (CI)), Crampin, E. J. (Chief Investigator (CI)), Boyd, B. (Chief Investigator (CI)), Cavalieri, F. (Chief Investigator (CI)) & Hodgkin, P. D. (Chief Investigator (CI))

  Project: Other

• Targeting interleukin-18-mediated inflammation to treat advanced kidney disease

  Drummond, G. (Primary Chief Investigator (PCI)), Vinh, A. (Chief Investigator (CI)), Jelinic, M. (Chief Investigator (CI)), Huuskes, B. (Chief Investigator (CI)), May, L. (Associate Investigator (AI)), Pinto, A. (Associate Investigator (AI)), Latz, E. (Associate Investigator (AI)), Ritchie, R. (Associate Investigator (AI)), Nold, C. (Associate Investigator (AI)) & Kovarik, J. (Associate Investigator (AI))

  Project: Research

• NSV Minor Project - Novel Drug Targets Formed By G-Protein Receptor Dimers

  Summers, R. (Primary Chief Investigator (PCI)), Evans, B. (Chief Investigator (CI)), Hutchinson, D. (Chief Investigator (CI)), Phiri, N. M. (Chief Investigator (CI)) & Popp, B. D. (Chief Investigator (CI))

  Project: Research

• A computer based approach to drug discovery: Identifying New Treatments for Osteoporosis and Asthma

  Keller, A. (Primary Chief Investigator (PCI)), Leach, K. (Chief Investigator (CI)), Gregory, K. (Chief Investigator (CI)) & Capuano, B. (Chief Investigator (CI))

  Project: Research